TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 29 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | -100.0% | 200 | -99.2% | 0.00% | -100.0% |
| Q2 2016 | $48,000 | +336.4% | 24,503 | +409.1% | 0.00% | +200.0% |
| Q1 2016 | $11,000 | -56.0% | 4,813 | +45.2% | 0.00% | -50.0% |
| Q4 2015 | $25,000 | +38.9% | 3,315 | -3.0% | 0.00% | +100.0% |
| Q3 2015 | $18,000 | -50.0% | 3,417 | -16.8% | 0.00% | -66.7% |
| Q2 2015 | $36,000 | – | 4,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 392,952 | $4,051,000 | 0.53% |
| BLUESTEIN R H & CO LLC | 179,800 | $1,854,000 | 0.12% |
| Edge Wealth Management LLC | 15,000 | $154,000 | 0.07% |
| Tower Research Capital LLC (TRC) | 1,316 | $14,000 | 0.00% |
| VANGUARD GROUP INC | 37,190 | $384,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 100 | $1,000 | 0.00% |
| UBS AG | 1,878 | $19,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 106 | $1,000 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 2,500 | $25,000 | 0.00% |
| CREDIT SUISSE AG/ | 19,370 | $200,000 | 0.00% |